Concepedia

Mark J. Hamblin

MJ

Statistics

Publications

12

Citations

917

H-Index

10

Active since

1990

Affiliations

Università Cattolica del Sacro Cuore(Current)

University of Kansas Medical Center

Charles University

University of Milano-Bicocca

University of California, San Francisco

Mark J. Hamblin is an author at Università Cattolica del Sacro Cuore specializing in life sciences, pulmonary fibrosis progression, and medicine.

Publications per year

1990–2022

12

Publications

12

Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis

Ganesh Raghu, Bernt van den Blink, Mark J. Hamblin et al. · JAMA · 2018 · 225 citations · Full text

, , +17

Infliximab for the treatment of CNS sarcoidosis

Jeffrey M. Gelfand, Michael Bradshaw, Barney J. Stern et al. · Neurology · 2017 · 185 citations · Full text

, , +8

Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study

Ganesh Raghu, Bernt van den Blink, Mark J. Hamblin et al. · The Lancet Respiratory Medicine · 2019 · 101 citations

, , +11

A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis

Ganesh Raghu, Majd Mouded, Daniel C. Chambers et al. · American Journal of Respiratory and Critical Care Medicine · 2022 · 101 citations

, , +14

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Diagnostic Dilemma

Mark J. Hamblin, Maureen R. Horton · Pulmonary Medicine · 2011 · 73 citations · Full text

, , +17

1–5 of 12